Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Biofil Chemicals & Pharmaceuticals (BIOFILCHEM) announced Q1 FY26 financial results, with net profit surging to ₹2.41 Cr from ₹0.17 Cr last year. This significant profit increase is attributed to the disposal of an undertaking. Revenue for the quarter was ₹6.43 Cr.

The board also approved re-appointing Mr. Ashok Kumar Ramawat and Mr. Satish Beohar as Independent Directors. Mr. Ketan Shah's role changed to Chairman and Managing Director. Other key decisions include forming a Finance Committee and shifting the registered office within Indore. The 40th Annual General Meeting is scheduled for September 27.